MarketPeel
Insider Trading Intelligence
MF

Mark Froimson

PCRX
DIRECTOR · PACIRA BIOSCIENCES, INC. · CIK 0001709050
FILING MIX · LIFETIME79%/21%
BUYS
15
SELLS
4
TOTAL VALUE
$139.5K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
10,891
AVG SELL PX
$55.20
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Mark Froimson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+5.81%+0.54%+5.27%+7.33%
14d4+50.00%+6.36%+0.49%+5.87%+6.21%
30d4+75.00%+2.53%+4.00%-1.46%-0.83%
60d4+75.00%+4.94%+5.79%-0.85%-3.38%
90d4+75.00%+7.73%+8.75%-1.02%-4.51%
180d4(1 pending)+100.00%+24.20%+7.27%+16.93%-11.54%
1y4(1 pending)+100.00%+23.64%+11.85%+11.79%-11.54%
2y4(2 pending)+100.00%-47.93%+17.57%-65.50%-65.50%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PCRX · 10,891 shares · as of Jun 10, 2026
06,63513,27119,90626,541202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 4 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
10,89110,891Jun 10, 2026Jun 12, 2026View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
6,40526,541Jun 10, 2026Jun 12, 2026View →
PCRX
PACIRA BIOSCIENCES, INC.
SALE
500$21.81$10.9K20,136Mar 17, 2026Mar 19, 2026View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
6,16320,636Jun 11, 2025Jun 13, 2025View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
11,27911,279Jun 11, 2025Jun 13, 2025View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASE
1,400$11.58$16.2K14,473Aug 12, 2024Aug 12, 2024View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
12,17912,179Jun 12, 2024Jun 13, 2024View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
5,23013,073Jun 12, 2024Jun 13, 2024View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,7757,843Jun 14, 2023Jun 16, 2023View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
12,92512,925Jun 14, 2023Jun 16, 2023View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,1606,068Jun 8, 2022Jun 8, 2022View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
8,2258,225Jun 8, 2022Jun 8, 2022View →
PCRX
PACIRA BIOSCIENCES, INC.
SALE
1,000$59.37$59.4K4,908May 9, 2022May 11, 2022View →
PCRX
PACIRA BIOSCIENCES, INC.
SALEGRANT
Gift
4005,908Dec 17, 2021Dec 20, 2021View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,0666,308Jun 9, 2021Jun 11, 2021View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
7,6267,626Jun 9, 2021Jun 11, 2021View →
PCRX
PACIRA BIOSCIENCES, INC.
SALE
734$72.26$53.0K5,242Mar 15, 2021Mar 17, 2021View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
8,0278,027Jun 9, 2020Jun 11, 2020View →
PCRX
PACIRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,2605,976Jun 9, 2020Jun 11, 2020View →
Other insiders · PCRX
Loading peer insiders…
About this filer
CIK 0001709050
ROLE
Director
PRIMARY
PCRX
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001709050DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback